Single User
£3188
PDF
60 pages

Varicose Veins Forecast in 15 Major Markets 2015-2025


There are three different types of varicose veins: trunk, reticular and telangiectasia. This indication report details the prevalence of trunk varicose veins. Trunk varicose veins are near to the surface of the skin and are thick and knobbly in appearance. The vein becomes incompetent and varicosities develop when a section with poorly functioning valves allows back-flow into the vein causing build-up of blood and distension of the vein.

This report provides the current prevalent population for varicose veins across 15 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Turkey, Mexico, Argentina, Poland, Russian Federation and China) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of segments affected, severity and patterns of varicose veins, to name a few. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of varicose veins have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for varicose veins include:

  • Deep vein thrombosis
  • Obesity
  • Hypertension
  • Phlebitis
  • Chronic venous insufficiency
  • Venous ulcer

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy
  • Able to quantify patient populations in global varicose veins’ market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of varicose veins and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on varicose veins’ prevalent population.
  • Identify sub-populations within varicose veins which require treatment.
  • Gain an understanding of the specific markets that have the largest number of varicose veins patients.
Table of Contents
  • List of Tables and Figures
  • Introduction
  • Cause of the Disease
  • Risk Factors and Prevention
  • Diagnosis of the Disease
  • Variation by Geography/ Ethnicity
  • Disease Prognosis and Clinical Course
  • Key Co-Morbid Conditions / Features associated with the Disease
  • Methodology for Quantification of Patient Numbers
  • Top-Line Prevalence for Varicose Veins
  • Features of Varicose Veins Patients
  • Associated Co-morbid Conditions of Varicose Veins
    • Reflux-related Conditions
    • Skin-related Conditions
  • Abbreviations used in the Report
  • Other Black Swan Analysis Publications
  • Black Swan Analysis Online Patient-Based Databases
  • Patient-Based Offering
  • Online Pricing Data and Platforms
  • References
  • Appendix
List of Tables
  • CEAP classification for varicose veins
  • Prevalence of varicose veins, total (000s)
  • Prevalence of varicose veins, males (000s)
  • Prevalence of varicose veins, females (000s)
  • Patterns of varicose veins in patients, total (000s)
  • Number of segments affected in patients with varicose veins, total (000s)
  • Severity of varicose veins by CEAP class in patients with varicose veins, total (000s)
  • Functional disease status of patients with varicose veins, total (000s)
  • Prevalence of GSV reflux in patients with varicose veins, total (000s)
  • Prevalence of saphenofemoral junction reflux in patients with varicose veins, total (000s)
  • Prevalence of saphenopopliteal junction reflux in patients with varicose veins, total (000s)
  • Prevalence of oedema in patients with varicose veins, total (000s)
  • Prevalence of skin changes in patients with varicose veins, total (000s)
  • Abbreviations and Acronyms used in the report
  • USA prevalence of varicose veins by 5-yr age cohort, males (000s)
  • USA prevalence of varicose veins by 5-yr age cohort, females (000s)
  • France prevalence of varicose veins by 5-yr age cohort, males (000s)
  • France prevalence of varicose veins by 5-yr age cohort, females (000s)
  • Germany prevalence of varicose veins by 5-yr age cohort, males (000s)
  • Germany prevalence of varicose veins by 5-yr age cohort, females (000s)
  • Italy prevalence of varicose veins by 5-yr age cohort, males (000s)
  • Italy prevalence of varicose veins by 5-yr age cohort, females (000s)
  • Spain prevalence of varicose veins by 5-yr age cohort, males (000s)
  • Spain prevalence of varicose veins by 5-yr age cohort, females (000s)
  • United Kingdom prevalence of varicose veins by 5-yr age cohort, males (000s)
  • United Kingdom prevalence of varicose veins by 5-yr age cohort, females (000s)
  • Brazil prevalence of varicose veins by 5-yr age cohort, males (000s)
  • Brazil prevalence of varicose veins by 5-yr age cohort, females (000s)
  • Japan prevalence of varicose veins by 5-yr age cohort, males (000s)
  • Japan prevalence of varicose veins by 5-yr age cohort, females (000s)
  • India prevalence of varicose veins by 5-yr age cohort, males (000s)
  • India prevalence of varicose veins by 5-yr age cohort, females (000s)
  • Turkey prevalence of varicose veins by 5-yr age cohort, males (000s)
  • Turkey prevalence of varicose veins by 5-yr age cohort, females (000s)
  • Mexico prevalence of varicose veins by 5-yr age cohort, males (000s)
  • Mexico prevalence of varicose veins by 5-yr age cohort, females (000s)
  • Poland prevalence of varicose veins by 5-yr age cohort, males (000s)
  • Poland prevalence of varicose veins by 5-yr age cohort, females (000s)
  • Argentina prevalence of varicose veins by 5-yr age cohort, males (000s)
  • Argentina prevalence of varicose veins by 5-yr age cohort, females (000s)
  • Russia prevalence of varicose veins by 5-yr age cohort, males (000s)
  • Russia prevalence of varicose veins by 5-yr age cohort, females (000s)
  • China prevalence of varicose veins by 5-yr age cohort, males (000s)
  • China prevalence of varicose veins by 5-yr age cohort, females (000s)
Argentina, Brazil, China, France, Germany, India, Italy, Japan, Mexico, Poland, Russian Federation, Spain, Turkey, United Kingdom, United States of America